We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.
Location: United Kingdom, England, Alderley Edge
Employees: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| 20.11.2022 | Perscitus ... | perscitusl... |